{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:54:17Z","timestamp":1789044857919,"version":"build-2803163510"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG063659"],"award-info":[{"award-number":["R01 AG063659"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["P30 MH62512"],"award-info":[{"award-number":["P30 MH62512"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["U24 MH100928"],"award-info":[{"award-number":["U24 MH100928"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH07345"],"award-info":[{"award-number":["R01 MH07345"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R25 MH081482"],"award-info":[{"award-number":["R25 MH081482"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P50 DA26306"],"award-info":[{"award-number":["P50 DA26306"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Alterations in brain function and structure, such as depression and neurocognitive impairment, continue to occur in people with human immunodeficiency virus (HIV, PWH) taking suppressive antiretroviral therapy (ART). The lifespan of PWH has improved but the healthspan remains worse than people without HIV, in part because of aging-related diseases. As a result, polypharmacy is common and increases the risk of drug-drug interactions and adverse reactions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This cross-sectional project investigated the relationship between 7 medication-related metrics (including anticholinergic burden), depressive symptoms, and neurocognitive performance in 491 PWH at a single center in the United States. All participants were taking ART and had plasma HIV RNA \u2264 200\u2005copies\/mL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Participants had taken ART for a mean of 6.5 years, and most (57.6%) had CD4+ T-cells &amp;gt;500\/\u00b5L. All 7 medication-related metrics were associated with worse global neurocognitive performance (P value &amp;lt;.0001 to .0087). Multivariable models confirmed that higher anticholinergic burden (P = .040) and use of benzodiazepines (P = .033), antidepressants (P = .0011), and more total medications (P = .059) were associated with more depressive symptoms (model P &amp;lt; .0001). Use of benzodiazepines (P = .0024) and opiates (P = .043) along with higher anticholinergic burden (P = .066) were also associated with worse neurocognitive performance. Benzodiazepine use was associated with worse performance in all domains and opiate use was associated with worse performance in processing speed, motor function, executive function, and working memory.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Use of benzodiazepines, opiates, and anticholinergic drugs contribute to cognitive and mood disorders in PWH. When possible, modifying or deprescribing medications may be beneficial.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciae518","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T04:25:22Z","timestamp":1732163122000},"page":"871-880","source":"Crossref","is-referenced-by-count":7,"title":["The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive Performance in People With HIV"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4001-0698","authenticated-orcid":false,"given":"Asante R","family":"Kamkwalala","sequence":"first","affiliation":[{"name":"Department of Neurology, Johns Hopkins University , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery","family":"Matthews","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Texas Health Science Center , San Antonio, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-6138","authenticated-orcid":false,"given":"Ankita","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University of Georgia , Athens, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upal","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Health and Biomedical Sciences, University of Texas Rio Grande Valley , Brownsville, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0123-9913","authenticated-orcid":false,"given":"Qing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University at Buffalo , Buffalo, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maile","family":"Karris","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-8035","authenticated-orcid":false,"given":"Erin","family":"Sundermann","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-752X","authenticated-orcid":false,"given":"Ronald J","family":"Ellis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California , San Diego, California ,","place":["USA"]},{"name":"Department of Neurosciences, University of California , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia K","family":"Riggs","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-719X","authenticated-orcid":false,"given":"Mattia","family":"Trunfio","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9699-318X","authenticated-orcid":false,"given":"David J","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah H","family":"Rubin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University , Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Psychiatry and Biological Sciences, Johns Hopkins University , Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Epidemiology, Johns Hopkins University , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3490-4975","authenticated-orcid":false,"given":"Scott L","family":"Letendre","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California , San Diego, California ,","place":["USA"]},{"name":"Department of Psychiatry, University of California , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"2025043020395031600_ciae518-B1","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1007\/s10461-018-2051-3","article-title":"Prevalence, comorbidity, and correlates of psychiatric and substance use disorders and associations with HIV risk behaviors in a multisite cohort of women living with HIV","volume":"22","author":"Cook","year":"2018","journal-title":"AIDS Behav"},{"key":"2025043020395031600_ciae518-B2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/PSY.0b013e31816aa0cc","article-title":"Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population","volume":"70","author":"Gaynes","year":"2008","journal-title":"Psychosom Med"},{"key":"2025043020395031600_ciae518-B3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.qai.0000219773.82055.aa","article-title":"Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United States","volume":"42","author":"Pence","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025043020395031600_ciae518-B4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0706743717737029","article-title":"Associations between depressive symptomatology and neurocognitive impairment in HIV\/AIDS","volume":"63","author":"Tymchuk","year":"2018","journal-title":"Can J Psychiatry"},{"key":"2025043020395031600_ciae518-B5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4088\/JCP.10m06304","article-title":"Gender, HIV status, and psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions","volume":"73","author":"Lopes","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"2025043020395031600_ciae518-B6","doi-asserted-by":"crossref","first-page":"e92842","DOI":"10.1371\/journal.pone.0092842","article-title":"Excess burden of depression among HIV-infected persons receiving medical care in the United States: data from the medical monitoring project and the behavioral risk factor surveillance system","volume":"9","author":"Do","year":"2014","journal-title":"PLoS One"},{"key":"2025043020395031600_ciae518-B7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-2006-956759","article-title":"Dementia and neurocognitive disorders due to HIV-1 infection","volume":"27","author":"Ances","year":"2007","journal-title":"Semin Neurol"},{"key":"2025043020395031600_ciae518-B8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/QAD.0b013e32835b1019","article-title":"Cognitive disorders in HIV-infected patients: are they HIV-related?","volume":"27","author":"Bonnet","year":"2013","journal-title":"AIDS"},{"key":"2025043020395031600_ciae518-B9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00002030-199304000-00011","article-title":"Neuropsychological performance in symptomatic and asymptomatic HIV infection","volume":"7","author":"Bornstein","year":"1993","journal-title":"AIDS"},{"key":"2025043020395031600_ciae518-B10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.neurobiolaging.2012.10.012","article-title":"Lower cognitive reserve in the aging human immunodeficiency virus-infected brain","volume":"34","author":"Chang","year":"2013","journal-title":"Neurobiol Aging"},{"key":"2025043020395031600_ciae518-B11","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1097\/QAD.0000000000003005","article-title":"Depression and HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014\u20132019","volume":"35","author":"Lesko","year":"2021","journal-title":"AIDS"},{"key":"2025043020395031600_ciae518-B12","doi-asserted-by":"crossref","first-page":"e25449","DOI":"10.1002\/jia2.25449","article-title":"The challenge of HIV treatment in an era of polypharmacy","volume":"23","author":"Back","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"2025043020395031600_ciae518-B13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/COH.0000000000000608","article-title":"Polypharmacy in HIV: recent insights and future directions","volume":"15","author":"Edelman","year":"2020","journal-title":"Curr Opin HIV AIDS"},{"key":"2025043020395031600_ciae518-B14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1076\/jcen.25.5.654.14577","article-title":"Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS)","volume":"25","author":"Farinpour","year":"2003","journal-title":"J Clin Exp Neuropsychol"},{"key":"2025043020395031600_ciae518-B15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2025043020395031600_ciae518-B16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12877-018-0789-0","article-title":"The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65\u201374 years and more than 75 years","volume":"18","author":"Guaraldi","year":"2018","journal-title":"BMC Geriatr"},{"key":"2025043020395031600_ciae518-B17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13803395.2013.783000","article-title":"The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals","volume":"35","author":"Patel","year":"2013","journal-title":"J Clin Exp Neuropsychol"},{"key":"2025043020395031600_ciae518-B18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jana.2010.04.002","article-title":"Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life","volume":"22","author":"Vance","year":"2011","journal-title":"J Assoc Nurses AIDS Care"},{"key":"2025043020395031600_ciae518-B19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s13365-020-00827-2","article-title":"Medication management abilities are reduced in older persons living with HIV compared with healthy older HIV- controls","volume":"26","author":"Cooley","year":"2020","journal-title":"J Neurovirol"},{"key":"2025043020395031600_ciae518-B20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/03007995.2020.1716706","article-title":"Retrospective analysis of comorbidities and treatment burden among patients with HIV infection in a US medicaid population","volume":"36","author":"DerSarkissian","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"2025043020395031600_ciae518-B21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/QAD.0000000000001756","article-title":"Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals","volume":"32","author":"Justice","year":"2018","journal-title":"AIDS"},{"key":"2025043020395031600_ciae518-B22","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","article-title":"Anticholinergic activity of 107 medications commonly used by older adults","volume":"56","author":"Chew","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"2025043020395031600_ciae518-B23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00002512-199303040-00004","article-title":"The problems of anticholinergic adverse effects in older patients","volume":"3","author":"Feinberg","year":"1993","journal-title":"Drugs Aging"},{"key":"2025043020395031600_ciae518-B24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neurobiolaging.2017.03.009","article-title":"Anticholinergic drug use is associated with episodic memory decline in older adults without dementia","volume":"55","author":"Papenberg","year":"2017","journal-title":"Neurobiol Aging"},{"key":"2025043020395031600_ciae518-B25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0006-8993(88)91227-9","article-title":"Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations","volume":"472","author":"Sunderland","year":"1988","journal-title":"Brain Res"},{"key":"2025043020395031600_ciae518-B26","first-page":"32","article-title":"Anticholinergic challenge and cognitive functions: a comparison between young and elderly normal subjects","volume":"28","author":"Zemishlany","year":"1991","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"2025043020395031600_ciae518-B27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00213-010-2153-8","article-title":"Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings","volume":"215","author":"Graef","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"2025043020395031600_ciae518-B28","first-page":"189","article-title":"Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain","volume":"2","author":"Perry","year":"1989","journal-title":"J Chem Neuroanat"},{"key":"2025043020395031600_ciae518-B29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pneurobio.2011.06.002","article-title":"Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging","volume":"94","author":"Bentley","year":"2011","journal-title":"Prog Neurobiol"},{"key":"2025043020395031600_ciae518-B30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0197-4580(80)90022-6","article-title":"Aging, memory, and the cholinergic system: a study of dichotic listening","volume":"1","author":"Drachman","year":"1980","journal-title":"Neurobiol Aging"},{"key":"2025043020395031600_ciae518-B31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","article-title":"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review","volume":"15","author":"Salahudeen","year":"2015","journal-title":"BMC Geriatr"},{"key":"2025043020395031600_ciae518-B32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s13365-020-00870-z","article-title":"Lifetime antiretroviral exposure and neurocognitive impairment in HIV","volume":"26","author":"Amusan","year":"2020","journal-title":"J Neurovirol"},{"key":"2025043020395031600_ciae518-B33","doi-asserted-by":"crossref","first-page":"604984","DOI":"10.3389\/fneur.2021.604984","article-title":"Patterns and predictors of cognitive function among virally suppressed women with HIV","volume":"12","author":"Dastgheyb","year":"2021","journal-title":"Front Neurol"},{"key":"2025043020395031600_ciae518-B34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jac\/dkad348","article-title":"Use of different anticholinergic scales and their correlation with anticholinergic symptom burden in a cohort of people living with HIV","volume":"79","author":"Mazzitelli","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2025043020395031600_ciae518-B35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/aid.2021.0231","article-title":"Degree of polypharmacy and cognitive function in older women with HIV","volume":"38","author":"Rubin","year":"2022","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025043020395031600_ciae518-B36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QAI.0000000000001755","article-title":"Cognitive burden of common non-antiretroviral medications in HIV-infected women","volume":"79","author":"Rubin","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025043020395031600_ciae518-B37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/QAI.0000000000002183","article-title":"Benzodiazepine use is associated with an increased risk of neurocognitive impairment in people living with HIV","volume":"82","author":"Saloner","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025043020395031600_ciae518-B38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s13365-022-01076-1","article-title":"The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV","volume":"28","author":"Sundermann","year":"2022","journal-title":"J Neurovirol"},{"key":"2025043020395031600_ciae518-B39","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1097\/QAD.0000000000001279","article-title":"Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice","volume":"30","author":"de Boer","year":"2016","journal-title":"AIDS"},{"key":"2025043020395031600_ciae518-B40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1517\/14740338.2013.823396","article-title":"Neuronal toxicity of efavirenz: a systematic review","volume":"12","author":"Decloedt","year":"2013","journal-title":"Expert Opin Drug Saf"},{"key":"2025043020395031600_ciae518-B41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s13365-015-0382-7","article-title":"Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients","volume":"22","author":"Ma","year":"2016","journal-title":"J Neurovirol"},{"key":"2025043020395031600_ciae518-B42","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1097\/QAD.0000000000002403","article-title":"Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV","volume":"33","author":"Mazzitelli","year":"2019","journal-title":"AIDS"},{"key":"2025043020395031600_ciae518-B43","volume-title":"Beck Depression Inventory\u2013II (BDI-II)","author":"Beck","year":"1996"},{"key":"2025043020395031600_ciae518-B44","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1080\/13854046.2012.694479","article-title":"Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings","volume":"26","author":"Blackstone","year":"2012","journal-title":"Clin Neuropsychol"},{"key":"2025043020395031600_ciae518-B45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/13803390490510031","article-title":"Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection","volume":"26","author":"Carey","year":"2004","journal-title":"J Clin Exp Neuropsychol"},{"key":"2025043020395031600_ciae518-B46","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/gps.4844","article-title":"Measuring anticholinergic exposure in patients with dementia: a comparative study of nine anticholinergic risk scales","volume":"33","author":"Turr\u00f3-Garriga","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"key":"2025043020395031600_ciae518-B47","doi-asserted-by":"crossref","first-page":"e1460","DOI":"10.1002\/wics.1460","article-title":"The akaike information criterion: background, derivation, properties, application, interpretation, and refinements","volume":"11","author":"Cavanaugh","year":"2019","journal-title":"WIREs Comput Stat"},{"key":"2025043020395031600_ciae518-B48","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1097\/QAD.0b013e328340a209","article-title":"A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people","volume":"24","author":"Bangsberg","year":"2010","journal-title":"AIDS"},{"key":"2025043020395031600_ciae518-B49","doi-asserted-by":"crossref","first-page":"e0245185","DOI":"10.1371\/journal.pone.0245185","article-title":"A comparison of medication adherence and viral suppression in antiretroviral treatment-na\u00efve patients with HIV\/AIDS depending on the drug formulary","volume":"16","author":"Oh","year":"2021","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"2025043020395031600_ciae518-B50","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1007\/s00406-010-0160-8","article-title":"Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade","volume":"260","author":"Voss","year":"2010","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2025043020395031600_ciae518-B51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0893-133X(96)00134-0","article-title":"Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans","volume":"16","author":"Vitiello","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"2025043020395031600_ciae518-B52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/JGP.0b013e3181602a2b","article-title":"Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women","volume":"16","author":"Dumas","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"2025043020395031600_ciae518-B53","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0278-5846(85)90034-X","article-title":"Mental dysfunction and the blockade of muscarinic receptors in the brains of the normal elderly","volume":"9","author":"Richardson","year":"1985","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2025043020395031600_ciae518-B54","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3233\/JAD-132345","article-title":"Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study","volume":"40","author":"Kilimann","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"2025043020395031600_ciae518-B55","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3233\/JAD-160778","article-title":"Hippocampus and basal forebrain volumetry for dementia and mild cognitive impairment diagno0sis: could it be useful in primary care?","volume":"55","author":"Teipel","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"2025043020395031600_ciae518-B56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JAD-150063","article-title":"Basal forebrain and hippocampus as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment\u2014a multicenter DTI and volumetry study","volume":"48","author":"Brueggen","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"2025043020395031600_ciae518-B57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-3806(97)00052-7","article-title":"Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging","volume":"101","author":"Court","year":"1997","journal-title":"Brain Res Dev Brain Res"},{"key":"2025043020395031600_ciae518-B58","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0165-0173(87)90007-5","article-title":"The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system","volume":"434","author":"Decker","year":"1987","journal-title":"Brain Res"},{"key":"2025043020395031600_ciae518-B59","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/QAI.0b013e318249db17","article-title":"Independent effects of HIV, aging, and HAART on brain volumetric measures","volume":"59","author":"Ances","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025043020395031600_ciae518-B60","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/01.wnl.0000218305.09183.70","article-title":"Altered hippocampal-prefrontal activation in HIV patients during episodic memory encoding","volume":"66","author":"Castelo","year":"2006","journal-title":"Neurology"},{"key":"2025043020395031600_ciae518-B61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archneur.1996.00550020059016","article-title":"Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection","volume":"53","author":"Kieburtz","year":"1996","journal-title":"Arch Neurol"},{"key":"2025043020395031600_ciae518-B62","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/01.aids.0000218552.69834.00","article-title":"Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment","volume":"20","author":"Moore","year":"2006","journal-title":"AIDS"},{"key":"2025043020395031600_ciae518-B63","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.neurobiolaging.2014.01.008","article-title":"Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study","volume":"35","author":"Pfefferbaum","year":"2014","journal-title":"Neurobiol Aging"},{"key":"2025043020395031600_ciae518-B64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/ageing\/afaa122","article-title":"The burden of psychotropic and anticholinergic medicines use in care homes: population-based analysis in 147 care homes","volume":"50","author":"Grill","year":"2021","journal-title":"Age and Ageing"},{"key":"2025043020395031600_ciae518-B65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13063-020-4089-6","article-title":"A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4\u20136 \u03bcg\/kg) in patients with major depressive disorder","volume":"21","author":"Chen","year":"2020","journal-title":"Trials"},{"key":"2025043020395031600_ciae518-B66","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","article-title":"Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial","volume":"63","author":"Furey","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"2025043020395031600_ciae518-B67","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s40266-017-0486-2","article-title":"Association between anticholinergic drug use and health-related quality of life in community-dwelling older adults","volume":"34","author":"Cossette","year":"2017","journal-title":"Drugs Aging"},{"key":"2025043020395031600_ciae518-B68","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41380-018-0219-x","article-title":"Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics","volume":"24","author":"Dulawa","year":"2019","journal-title":"Mol Psychiatry"},{"key":"2025043020395031600_ciae518-B69","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"2025043020395031600_ciae518-B70","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1124\/jpet.123.001651","article-title":"Hydrocodone, oxycodone, and morphine metabolism and drug-drug interactions","volume":"387","author":"Coates","year":"2023","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae518\/61016721\/ciae518.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/4\/871\/61016721\/ciae518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/4\/871\/61016721\/ciae518.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:40:08Z","timestamp":1746060008000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/4\/871\/7919865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,10]]},"published-print":{"date-parts":[[2025,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae518","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4,15]]},"published":{"date-parts":[[2024,12,10]]}}}